Kynurenine monooxygenase (KMO) plays a major role in the regulation of inflammation and how the immune system is controlled by inflammation and metabolism. These conditions can be acute, for example critical illness or major surgery, or more long-standing, for example endometriosis and cancers that have evaded the immune system. All these scenarios have a pressing need for new medicines.